Literature DB >> 34028403

COVID Lessons Continue: Postvaccination Somatostatin Receptor-Positive Axillary Nodes on DOTATATE Imaging.

Hina J Shah, Jason I Halpern, Gaurav V Watane, Hyewon Hyun.   

Abstract

ABSTRACT: COVID vaccination has begun in most of the countries. Older population and high-risk groups are prioritized for vaccination. Postvaccination imaging in cancer patients may show effects of the immune response to the vaccine. As such, it is important to know the timing and laterality of the vaccination as the reactive lymph nodes in the ipsilateral axilla can be seen on the imaging. We present a case of DOTATATE-avid nonpathologically enlarged lymph nodes in ipsilateral axilla and linear tracer uptake in the deltoid muscle on a patient imaged for a recent diagnosis of rectal neuroendocrine neoplasm.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34028403     DOI: 10.1097/RLU.0000000000003757

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT.

Authors:  Mohamed S El-Sayed; Godfrey N Wechie; Chen Sheng Low; Oludolapo Adesanya; Nikhil Rao; Vincent J Leung
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

2.  Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.

Authors:  Loic Ah-Thiane; Ludovic Ferrer; Bruno Maucherat; Vincent Fleury; Maelle Le Thiec; Daniela Rusu; Caroline Rousseau
Journal:  Clin Nucl Med       Date:  2022-04-27       Impact factor: 10.782

3.  COVID-19 Vaccination Manifesting as Unilateral Lymphadenopathies Detected by 18F-Choline PET/CT.

Authors:  Domenico Albano; Giulia Volpi; Francesco Dondi; Raffaele Giubbini; Francesco Bertagna
Journal:  Clin Nucl Med       Date:  2022-02-01       Impact factor: 7.794

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.